Bupropion in the treatment of outpatients with asthma and major depressive disorder

International Journal of Psychiatry in Medicine

Volumn 37, Issue 1, 2007, Pages 23-28

  Brown, E Sherwood ^a   Vornik, Lana A ^a   Khan, David A ^a   Rush, A John ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Asthma; Bupropion; Major depressive disorder

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; ASTHMA; CLINICAL ARTICLE; FEMALE; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MALE; OPEN STUDY; OUTPATIENT; PILOT STUDY; QUESTIONNAIRE; SPIROMETRY; TREATMENT RESPONSE; AMBULATORY CARE; ANXIETY DISORDER; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; PERSONALITY TEST; PSYCHOLOGICAL RATING SCALE; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL; STATISTICS; TREATMENT OUTCOME;

AMBULATORY CARE; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANXIETY DISORDERS; ASTHMA; BUPROPION; CITALOPRAM; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; HUMANS; PERSONALITY INVENTORY; PILOT PROJECTS; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; QUESTIONNAIRES; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 34547611313     PISSN: 00912174     EISSN: 15413527     Source Type: Journal    
DOI: 10.2190/D235-2285-2121-6724     Document Type: Article

References (6)

1. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry 1994;51:8-19.
2. Zielinski TA, Brown ES, Nejtek VA, Khan DA, Moore JJ, Rush AJ. Depression in asthma: prevalence and clinical implications. Primary Care Companion Journal of Clinical Psychiatry 2000;2:153-158.
3. Brown ES, Vigil L, Khan DA, Liggin JD, Carmody TJ, Rush AJ. A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study. Biological Psychiatry 2005;58:865-870.
4. Thase ME, Haight BR, Richard N, Rockett CB, Mitton M, Modell JG, VanMeter S, Harriett AE, Wang Y. Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials. Journal of Clinical Psychiatry 2005;66:974-981.
5. Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, and the STAR*D Study Team. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. New England Journal of Medicine 2006;354:1231-1242.
6. Zimmerman M, Posternak MA, Attiullah N, Friedman M, Boland RJ, Baymiller S, Berlowitz SL, Rahman S, Uy KK, Singer S, Chelminski I. Why isn't bupropion the most frequently prescribed antidepressant? Journal of Clinical Psychiatry 2005;66:603-610.